GangaGen Secures additional US$7.9 Million from CARB-X for Pre-clinical Development of Novel Klebicins Targeting Nosocomial Pneumonia caused by Multidrug-resistant Klebsiella pneumoniae

Published on December 24, 2024

announced today that it has secured the third instalment of its phased funding grant from CARB-X (Combating Antibiotic-Resistant Bacteria

Continue reading on website
Other news

Here are the education issues Indiana lawmakers are considering for the 2025 legislative session

December 24, 2024
aid could mean over 25,000 families will lose funding for child care unless the state supplements the funding.The department already in

Retail recruitment: how to recruit staff for your shop

December 24, 2024
Startups.co.uk is reader supported – we may earn a commission from our recommendations, at no extra cost to you and without impacting our